Esomeprazole is a proton pump inhibitor used to reduce gastric acid secretion, effectively treating conditions such as gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome. This… Read more



![Chemical structure of (S)-(4-Methoxy-6-(((6-(methoxymethyl)-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-5-methylpyridin-3-yl)methanol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F19648-27-7-S-4-Methoxy-6-6-methoxymethyl-1H-benzodimidazol-2-ylsulfinylmethyl-5-methylpyridin-3-ylmethanol.png&w=3840&q=75)
![Chemical structure of (S)-2-(((4-Methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazol-6-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F358675-51-1-S-2-4-Methoxy-35-dimethylpyridin-2-ylmethylsulfinyl-1H-benzodimidazol-6-ol.png&w=3840&q=75)
![Chemical structure of (S)-2-(((5-Methoxy-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3,5-dimethylpyridin-4(1H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FS-2-5-Methoxy-1H-benzodimidazol-2-ylsulfinylmethyl-35-dimethylpyridin-41H-one.png&w=3840&q=75)

![Chemical structure of (S)-6-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1-methyl-1H-benzo[d]imidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1346240-11-6-S-6-Methoxy-2-4-methoxy-35-dimethylpyridin-2-ylmethylsulfinyl-1-methyl-1H-benzodimidazole.png&w=3840&q=75)

![Chemical structure of 1-(5-Methoxy-1H-benzo[d]imidazol-2-yl)-2,3,5-trimethylpyridin-4(1H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2512216-37-2-1-5-Methoxy-1H-benzodimidazol-2-yl-235-trimethylpyridin-41H-one.png&w=3840&q=75)
![Chemical structure of 1-(6-Methoxy-1H-benzo[d]imidazol-2-yl)-3,5-dimethyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2172852-91-2-1-6-Methoxy-1H-benzodimidazol-2-yl-35-dimethyl-4-oxo-14-dihydropyridine-2-carboxylic-acid-Hydrochloride.png&w=3840&q=75)

![Chemical structure of 2-(((3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F704910-88-3-2-35-dimethylpyridin-2-ylmethylsulfinyl-1H-benzodimidazole.png&w=3840&q=75)
![Chemical structure of 2-(((4-Methoxy-3,5-dimethylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F73590-87-1-2-4-Methoxy-35-dimethylpyridin-2-ylmethylthio-1H-benzodimidazole.png&w=3840&q=75)
![Chemical structure of 2-(((6-Methoxy-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3,5-dimethylpyridin-4(1H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2362529-32-4-2-6-Methoxy-1H-benzodimidazol-2-ylsulfinylmethyl-35-dimethylpyridin-41H-one.png&w=3840&q=75)









![Chemical structure of 4-Methoxy-1,3-dihydro-2H-benzo[d]imidazole-2-thione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F149367-83-9-4-Methoxy-13-dihydro-2H-benzodimidazole-2-thione.png&w=3840&q=75)

![Chemical structure of 5-Methoxy-1-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfonyl)-1H-benzo[d]imidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1346599-74-3-5-Methoxy-1-4-methoxy-35-dimethylpyridin-2-ylmethyl-2-4-methoxy-35-dimethylpyridin-2-ylmethylsulfonyl-1H-benzodimidazole.png&w=3840&q=75)
![Chemical structure of 5-Methoxy-1-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1346600-29-0-5-Methoxy-1-4-methoxy-35-dimethylpyridin-2-ylmethyl-2-4-methoxy-35-dimethylpyridin-2-ylmethylthio-1H-benzodimidazole.png&w=3840&q=75)
![Chemical structure of 5-Methoxy-2-((2,3,5-trimethylpyridin-4-yl)oxy)-1H-benzo[d]imidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5-Methoxy-2-235-trimethylpyridin-4-yloxy-1H-benzodimidazole.png&w=3840&q=75)
![Chemical structure of 5-Methoxybenzo[d]oxazole-2-thiol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F49559-83-3-5-Methoxybenzodoxazole-2-thiol.png&w=3840&q=75)
![Chemical structure of 6-methoxy-1-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2101206-66-8-6-methoxy-1-4-methoxy-35-dimethylpyridin-2-ylmethyl-2-4-methoxy-35-dimethylpyridin-2-ylmethylsulfinyl-1H-benzodimidazole.png&w=3840&q=75)
![Chemical structure of 6-Methoxy-1-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfonyl)-1H-benzo[d]imidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2101206-41-9-6-Methoxy-1-4-methoxy-35-dimethylpyridin-2-ylmethyl-2-4-methoxy-35-dimethylpyridin-2-ylmethylsulfonyl-1H-benzodimidazole.png&w=3840&q=75)
![Chemical structure of 6-Methoxy-1H-benzo[d]imidazole-2-sulfinic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1080689-87-7-6-Methoxy-1H-benzodimidazole-2-sulfinic-acid.png&w=3840&q=75)









![Chemical structure of Mixture of (S)-5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1-methyl-1H-benzo[d]imidazole and (S)-6-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1-methyl-1H-benzo[d]imidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FMixture-of-S-5-Methoxy-2-4-methoxy-35-dimethylpyridin-2-ylmethylsulfinyl-1-methyl-1H-benzodimidazole-and-S-6-Methoxy-2-4-methoxy-35-dimethylpyridin-2-.png&w=3840&q=75)


Esomeprazole is a proton pump inhibitor used to reduce gastric acid secretion, effectively treating conditions such as gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome. This category provides essential reference standards for Esomeprazole, including pharmacopeial and non-pharmacopeial impurities, specific metabolites, and stable isotope labelled compounds. Pharmaceutical laboratories utilize these high-quality materials for critical analytical processes, such as method validation, impurity profiling, and quality control assessments. Stable isotope labelled versions are particularly valuable as internal standards for mass spectrometry and quantitative pharmacokinetic studies. By maintaining a comprehensive collection of these related substances, analytical scientists can ensure accurate identification and quantification of impurities, supporting robust drug development and regulatory compliance. These materials provide the necessary benchmarks to verify the identity, purity, and potency of the drug substance throughout its lifecycle, ensuring consistency in therapeutic performance and safety.